RE: SP predictions11 Jan 2023 14:11
whilst i do check the ADVFN board everyday,i only do so to see if anything factual ever gets posted.i had enough of booth on here to last me several lifetimes! on the question of resources, the comment on advfn seems an example of indiscriminate thinking (perhaps motivated by an agenda (heaven forbid). imo, one needs to read carefully the various RNSs regarding the various deals,as they all have different terms.for example,the cooper one from 23rd of may states that cooper will be responsible for all launch and marketing expenses. futura remains the legal manufacturer and will be responsible for the supply of Med3000 through its third party contract manufacturer. cooper is to pay an agreed price to futura for the manufacture and supply of med3000 by its 3rd party contractor.
whilst it is not completely clear what precisely this means, it does not seem to suggest that fum will have massively onerous manufacturing costs and in any event coopers are going to pay something for them ,as well as bearing marketing costs.what "launch :costs means it no doubt open to interpretation,but im personally not expecting any fund raise in advance of launch news in EU and the FDA trial outcome.if funds are needed for US launch then that is something that can be considered when the question of approval has been answered.